Table 5.
Characteristics | Overall | Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | P-value |
---|---|---|---|---|---|---|
n=751 | n=189 | n=188 | n=187 | n=187 | ||
0.17-1.83 | 1.84-2.47 | 2.48-3.23 | ≥3.24 | |||
Mean follow-up time (months) | 78.2±15.79 | 80.83±12.13 | 80.3±12.13 | 79.37±14.36 | 72.25±20.65 | <0.001* |
MACCE-free survival | 76.03±18.35 | 80.03±13.41 | 79.83±13.81 | 76.66±18.33 | 67.32±23.33 | <0.001* |
MACCE (1 year) | 23 (3.1) | 1 (0.5) | 2 (1.1) | 7 (3.7) | 13 (7) | 0.001* |
MACCE (3 years) | 42 (5.5) | 3 (1.6) | 7 (4.3) | 8 (4.3) | 24 (12.8) | <0.001* |
MACCE (7.8 years) | 87 (11.6) | 11 (5.8) | 7 (3.7) | 20 (10.8) | 49 (26.5) | <0.001* |
STEMI | 31 (4.1) | 3 (1.6) | 3 (1.6) | 7 (3.7) | 19 (10.2) | <0.001* |
Stroke | 23 (3.1) | 3 (1.6) | 3 (1.6) | 4 (2.1) | 13 (7) | 0.005* |
Late reintervention | 34 (4.6) | 3 (1.6) | 0 | 11 (5.8) | 20 (10.7) | <0.001* |
PCI | 30 (4) | 3 (1.6) | 0 | 10 (5.3) | 17 (9.1) | <0.001* |
Redo-CABG | 2 (0.3) | 0 | 0 | 0 | 2 (1.1) | 0.1 |
Pacemaker | 2 (0.3) | 0 | 0 | 1 (0.5) | 1 (0.5) | 0.56 |
All-cause mortality | 60 (8) | 8 (4.2) | 9 (4.8) | 15 (8) | 28 (15) | <0.001* |
Cardiovascular mortality | 40 (5.3) | 3 (1.6) | 5 (2.7) | 8 (4.3) | 25 (13.4) | <0.001* |
Non-cardiovascular mortality | 19 (2.6) | 5 (2.6) | 4 (2.1) | 7 (3.7) | 3 (1.6) | 0.62 |
Statistically significant difference. Values are represented as mean ± standard deviation and number (%), where appropriate. CABG=coronary artery bypass grafting; MACCE=major adverse cardiac and cerebrovascular event; PCI=percutaneous coronary intervention; STEMI=ST elevation myocardial infarction